HS2ST1 and hepatocellular carcinoma: To further explore how high HS2ST1 expression levels might contribute to the poor prognosis of HCC patients, we identified DEGs in the TCGA-LIHC cohort and enriched gene sets in the high-HS2ST1 expression group.